In Brief | 

Unveiling the Role of Seizure Prophylaxis in Mild and Moderate Traumatic Brain Injury
 
Estimated read time: 1 minute, 06 seconds

 
Published on MedED: 17 April 2024
Originally Published: 8 April 2024
Sourced: JAMA Neurology
Type of article: In Brief
MedED Catalogue Reference: MCCIB010

Category: Critical Care, Anaesthetics & Emergency Medicine
Cross Reference: Neurology

Keywords: TBI, trauma, posttraumatic seizure, PTS, seizure prophylaxis

Top


This is a synopsis of original peer-reviewed clinical research published in JAMA Neurology, 8 April 2024

The use of seizure prophylaxis after mild to moderate traumatic brain injury (TBI) remains a topic of debate, despite established guidelines advocating its use in severe cases. This study aimed to clarify the relationship between seizure prophylaxis and the reduction of early posttraumatic seizures (PTS) in mild and moderate TBI. 

Conducted across multiple trauma centres in high-income countries, this observational analysis involved 8 studies comprising 5637 patients with mild to moderate TBI and 5 studies including 3803 patients with mild TBI.

The researchers report that the absolute risk reduction associated with seizure prophylaxis for early posttraumatic seizures (PTS) in mild to moderate traumatic brain injury (TBI) cases with a Glasgow Coma Scale (GCS) of 9-15 was 0.6% (95% CI, 0.1%-1.2%; P = .02). Similarly, for mild TBI alone, the absolute risk reduction was 0.6% (95% CI, 0.01%-1.2%; P = .04). 


While the results suggest that providing seizure prophylaxis was associated with a slight reduction in the risk of early posttraumatic seizures among individuals with mild to moderate traumatic brain injury, the researchers emphasize the importance of weighing these benefits against the potential risks of prescribing antiseizure medications.

 

Access the original article
Pease M, Mittal A, Merkaj S, et al. Early Seizure Prophylaxis in Mild and Moderate Traumatic Brain Injury: A Systematic Review and Meta-Analysis. JAMA Neurol. Published online April 08, 2024. doi:10.1001/jamaneurol.2024.0689



Back to top


Disclaimer
This article is compiled from several resources researched and compiled by the contributor. It is in no way presented as an original work.  Every effort has been made to attribute quotes and content correctly. Where possible all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us 


Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.

Rapid SSL

The Medical Education Network
Powered by eLecture, a VisualLive Solution